{
"html_url": "https://licitia.com.mx/adjudicacion/aa-12-ndf-012ndf999-i-355-2023",
"canonical": "https://licitia.com.mx/adjudicacion/aa-12-ndf-012ndf999-i-355-2023",
"id": "36e4e2f9a0ab407385c31ca1a90bafb5",
"procedure_number": "AA-12-NDF-012NDF999-I-355-2023",
"file_number": "E-2023-00047236",
"title": "INR/2023/525",
"description": {
"short": "No existen bienes alternativos o sustitutos, Único Oferente, Derechos exclusivos (patentes, licencias, derechos de autor u otros derechos exclusivos), o por obras de arte.",
"detailed": "LICITACION PUBLICA INTERNACIONAL LA-012M7B997-E133-2022\nCIPROFLOXACINO. SUSPENSIÓN ORAL. CADA 5 MILILITROS CONTIENEN: CLORHIDRATO DE\nCIPROFLOXACINO EQUIVALENTE A 250 MG DE CIPROFLOXACINO O CIPROFLOXACINO 250 MG.\nENVASE CON MICROESFERAS CON 5 G Y ENVASE CON DILUYENTE CON 93 ML."
},
"lifecycle": {
"section": "concluido",
"source_status": "ADJUDICADO",
"moved_at": null
},
"buyer": {
"agency": "INSTITUTO NACIONAL DE REHABILITACIÓN LUIS GUILLERMO IBARRA IBARRA",
"acronym": "INR",
"branch": "12 - SALUD",
"buying_unit": "SUBDIRECCION DE COMPRAS Y SUMINISTROS",
"requesting_unit": "unidad requiriente data",
"requesting_group": "SUBDIRECCION DE COMPRAS Y SUMINISTROS",
"entity": "instituto nacional de rehabilitacion luis guillermo ibarra ibarra",
"slug": "inr",
"unit_slug": "subdireccion-de-compras-y-suministros-012ndf999"
},
"classification": {
"procedure_type": "ADJUDICACIÓN DIRECTA",
"contracting_type": "ADQUISICIONES",
"publication_type": null,
"character": "INTERNACIONAL ABIERTO",
"fiscal_year": 2023,
"law": "LEY DE ADQUISICIONES, ARRENDAMIENTOS Y SERVICIOS DEL SECTOR PÚBLICO",
"legal_basis_id": "22",
"exception_basis": "Art. 41 fr. I",
"internal_control_number": "INR/2023/525",
"supply_source_number": null
},
"schedule": {
"published_at": "2023-06-14T03:17:48.000Z",
"clarification_meeting_at": null,
"clarification_questions_deadline_at": null,
"clarification_responses_deadline_at": null,
"bid_opening_at": null,
"award_at": null,
"estimated_contract_at": "2023-06-08T06:00:00.000Z",
"site_visit_at": null,
"estimated_work_start_at": null
},
"estimated_value": {
"minimum": null,
"maximum": null,
"currency": "MXN",
"updated_at": null
},
"lots": [
{
"number": "1",
"name": "PARTIDA SOLA",
"description": "PARTIDA SOLA",
"requirement_group_id": "1",
"items": [
{
"number": "1",
"cucop_code": "25301-0497",
"specific_item_code": "25301",
"cucop_description": "010.000.4258.00 CIPROFLOXACINO SUSPENSION 250 MG/5 ML ENVASE CON 5 G Y 93 ML DE DILUYENTE",
"description": "CIPROFLOXACINO. SUSPENSIÓN ORAL. CADA 5 MILILITROS CONTIENEN: CLORHIDRATO DE\nCIPROFLOXACINO EQUIVALENTE A 250 MG DE CIPROFLOXACINO O CIPROFLOXACINO 250 MG.\nENVASE CON MICROESFERAS CON 5 G Y ENVASE CON DILUYENTE CON 93 ML.",
"requested_quantity": "200",
"minimum_quantity": "200",
"maximum_quantity": null,
"unit": "PIEZA",
"minimum_amount": null,
"maximum_amount": null
}
]
}
],
"awards": [
{
"id": "C-2023-00055557",
"internal_reference": "INR/2023/525",
"title": "INR/2023/525",
"status": "PUBLICADO",
"contractor": {
"name": "BAYER DE MEXICO SA DE CV",
"normalized_name": "BAYER DE MEXICO",
"rfc_type": null,
"slug": "bayer-de-mexico"
},
"contract_period": {
"published_at": "2023-06-14T03:17:48.000Z",
"starts_at": "2023-06-08T06:00:00.000Z",
"ends_at": "2023-06-22T06:00:00.000Z"
},
"value": {
"subtotal": "54324",
"tax": "0",
"total": "54324",
"maximum_subtotal": "0",
"maximum_total": "0",
"currency": "MXN"
},
"open_contract_type": null,
"quantity": null,
"exercised_quantity": null,
"participants": [],
"line_items": [
{
"number": "0",
"cucop_code": "25301-0497",
"description": "CIPROFLOXACINO. SUSPENSIÓN ORAL. CADA 5 MILILITROS CONTIENEN: CLORHIDRATO DE\nCIPROFLOXACINO EQUIVALENTE A 250 MG DE CIPROFLOXACINO O CIPROFLOXACINO 250 MG.\nENVASE CON MICROESFERAS CON 5 G Y ENVASE CON DILUYENTE CON 93 ML.",
"unit": "PIEZA",
"requested_quantity": "200",
"awarded_quantity": null,
"unit_price": "271.62",
"subtotal": "54324",
"tax": null,
"other_taxes": null,
"total": "54324"
}
]
}
],
"documents": [
{
"id": null,
"annex_number": 1,
"document_type": null,
"description": "JUSTIFICACIÓN DE EXCEPCIÓN",
"filename": "Requisición 230355-C.pdf",
"availability": "available",
"size_bytes": "1018706",
"mime_type": "application/pdf",
"sha256": "6da7edac470d06a8495a22acfddf43fc4e75e31c224480888411a36068f98aa7",
"uploaded_at": "2025-12-07T13:21:10.043Z",
"updated_at": "2026-08-05T21:42:38.885Z"
},
{
"id": null,
"annex_number": 4,
"document_type": null,
"description": "OFICIO DE ADJUDICACIÓN",
"filename": "Requisición 230355-C.pdf",
"availability": "available",
"size_bytes": "1018706",
"mime_type": "application/pdf",
"sha256": "6da7edac470d06a8495a22acfddf43fc4e75e31c224480888411a36068f98aa7",
"uploaded_at": "2025-12-07T13:21:14.013Z",
"updated_at": "2026-08-05T21:42:38.885Z"
}
],
"alternates": [],
"similar": [
{
"numero_procedimiento": "aa-12-ndf-012ndf999-n-755-2023",
"nombre_procedimiento": "CONSOLIDADO/INSABI/INRLGII/96/2023-2024 BAYER DE MÉXICO, S.A. DE C.V",
"dependencia": "INSTITUTO NACIONAL DE REHABILITACIÓN LUIS GUILLERMO IBARRA IBARRA",
"siglas": "INR",
"score": 0.019071159473512456
},
{
"numero_procedimiento": "aa-50-gyr-050gyr082-n-113-2023",
"nombre_procedimiento": "D3P0168\tFARMACEUTICA HN, S.A DE C.V.",
"dependencia": "IMSS",
"siglas": "IMSS",
"score": 0.15384564949921375
},
{
"numero_procedimiento": "aa-50-gyr-050gyr041-n-122-2024",
"nombre_procedimiento": "ADJ-MED-101-2024",
"dependencia": "IMSS",
"siglas": "IMSS",
"score": 0.15681860961691618
},
{
"numero_procedimiento": "aa-50-gyr-050gyr041-n-198-2024",
"nombre_procedimiento": "ADQUISICIÓN DE MEDICAMENTOS",
"dependencia": "IMSS",
"siglas": "IMSS",
"score": 0.15772990492225225
},
{
"numero_procedimiento": "aa-50-gyr-050gyr082-n-133-2024",
"nombre_procedimiento": "MEDICAMENTOS MARZO",
"dependencia": "IMSS",
"siglas": "IMSS",
"score": 0.16032587526285047
},
{
"numero_procedimiento": "aa-50-gyr-050gyr018-i-446-2023",
"nombre_procedimiento": "ADQUISICION DE MEDICAMENTO GPO 010",
"dependencia": "IMSS",
"siglas": "IMSS",
"score": 0.16096802106784658
}
]
}